"Patients are likely to face substantially higher out-of-pocket costs for bempedoic acid than for a generic statin," says a cardiologisthttps://ift.tt/P1GWyQ8
"Patients are likely to face substantially higher out-of-pocket costs for bempedoic acid than for a generic statin," says a cardiologist